GILEAD SCIENCES, INC. - Common Stock (GILD)

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock
Shares outstanding
1,240,722,841
Total 13F shares
1,023,306,837
Share change
-22,798,175
Total reported value
$74,925,010,043
Put/Call ratio
93%
Price per share
$73.25
Number of holders
1,695
Value change
-$1,831,705,930
Number of buys
737
Number of sells
880

Institutional Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q1 2024

As of 31 Mar 2024, GILEAD SCIENCES, INC. - Common Stock (GILD) was held by 1,695 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,023,306,837 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, Capital Research Global Investors, STATE STREET CORP, Dodge & Cox, GEODE CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, MORGAN STANLEY, and FMR LLC. This page lists 1,706 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.